IRIS
ANNESE, VITO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.106
NA - Nord America 241
AS - Asia 221
SA - Sud America 5
OC - Oceania 2
Totale 1.575
Salva come PNG Salva come JPEG
Nazione #
CZ - Repubblica Ceca 826
US - Stati Uniti d'America 237
SG - Singapore 145
RU - Federazione Russa 107
CN - Cina 62
IT - Italia 56
SE - Svezia 56
FI - Finlandia 26
DE - Germania 15
NL - Olanda 6
BR - Brasile 5
TW - Taiwan 5
HK - Hong Kong 4
MX - Messico 4
GR - Grecia 3
AT - Austria 2
DK - Danimarca 2
ES - Italia 2
FR - Francia 2
PL - Polonia 2
TR - Turchia 2
VN - Vietnam 2
AU - Australia 1
IE - Irlanda 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 1.575
Salva come PNG Salva come JPEG
Città #
Olomouc 826
Singapore 80
New York 58
Moscow 39
Ashburn 37
Shanghai 33
Helsinki 25
Lawrence 24
Princeton 23
Milan 13
Dallas 6
Los Angeles 6
Rome 6
Boardman 5
Seattle 5
Xizhi District 5
Guangzhou 4
Athens 3
Beijing 3
Brescia 3
Columbus 3
Jiaxing 3
Munich 3
Santa Clara 3
St Louis 3
Amsterdam 2
Bologna 2
Camogli 2
Florence 2
Fort Worth 2
Hvidovre 2
Lublin 2
Malnate 2
Ravenna 2
Rio de Janeiro 2
Springfield 2
Taizhou 2
Turin 2
Vienna 2
Abbiategrasso 1
Bagnolo Mella 1
Bari 1
Buffalo 1
Council Bluffs 1
Edinburg 1
Espoo 1
Falkenstein 1
Hong Kong 1
Hung Hom 1
Istanbul 1
Kaitangata 1
Madrid 1
Paris 1
Prineville 1
Reading 1
Reggio Emilia 1
Shenzhen 1
Sydney 1
Venice 1
Wuxi 1
Xi'an 1
Totale 1.269
Salva come PNG Salva come JPEG
Nome #
An update on treatment of ulcerative colitis 95
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 94
Authors' answers on comment of Abellona et al. on Metabolomic analysis for noninvasive diagnosis of hepatic fibrosis degree in patients with chronic hepatitis C 92
Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial 92
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 92
Biosimilars in IBD: Similarity Breeds Contented Patients 90
IBD and malignancies: The gender matters 89
Comparative efficacy of first-line therapeutic interventions for achalasia: a systematic review and network meta-analysis 89
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus 88
Global variability of the human IgG glycome 87
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial 87
Fundoplication: Old Concept for Novel Challenges? 33
Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 19
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 17
The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars 17
A multicenter randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group 16
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 16
Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases 16
Risk factor analysis for therapy related adverse events and infections in elder patients with Inflammatory Bowel Disease; An analysis from the IG-IBD aged study 15
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects 14
A further "stri(v)de" in IBD management 14
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment 14
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial 14
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease 13
Genetics and epigenetics of IBD 13
10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy 13
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 13
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications 12
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 12
Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates 11
Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 11
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 11
Computed tomography or contrast-enhanced ultrasonography for follow-up of liver metastases after Cyberknife therapy?: A prospective pilot study 11
The "Hub and Spoke" model has no effect on mortality in acute upper gastrointestinal bleeding: A prospective multicenter cohort study 11
The interaction of patients’ physical status and time to endoscopy on mortality risk in patients with upper gastrointestinal bleeding: A national prospective cohort study 10
Prevalence and Predictors of Reduced Bone Density in Child and Adolescent Patients With Crohn's Disease 10
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use 10
Adalimumab in active ulcerative colitis: A "real-life" observational study 10
Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population 9
Italian consensus conference for colonic diverticulosis and diverticular disease 9
Prospective observational study on inflammatory bowel disease patients treated with infliximab biosimilars: preliminary results of the PROSIT-BIO cohort of the IG-IBD 9
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 9
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study 9
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission 8
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease 8
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 8
Peroral Endoscopic Myotomy for the Treatment of Esophageal Diverticula: A Systematic Review and Meta-analysis 7
TDM of Anti-TNF Agents: The Importance of Being Active! 7
Prospective Evaluation of Liver Stiffness Using Transient Elastography in Alcoholic Patients following Abstinence 7
Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases 7
Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease 7
Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases 7
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study 7
THE HLA-DQΒ1 INSERTION IS A STRONG ACHALASIA RISK FACTOR AND DISPLAYS A GEOSPATIAL NORTH-SOUTH GRADIENT AMONG EUROPEANS 7
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 7
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 7
Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients 6
Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016 6
Composition of the gut microbiota in patients with inflammatory bowel disease in Saudi Arabia: A pilot stud 6
Beclomethasone dipropionate for the treatment of ulcerative colitis 6
Dual-channel endoscope for double-traction endoscopic device-assisted full-thickness resection of rectal superficial tumor 6
Disease patterns in late-onset ulcerative colitis: Results from the " IG-IBD ""AGED study""" 6
Precision Medicine in Inflammatory Bowel Disease 6
Outcomes of treatment for achalasia depend on manometric subtype 5
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 5
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment 5
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: A genetic association study 5
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis 5
Pre- and post-procedural quality indicators for colonoscopy: A nationwide survey 5
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease 5
Gastrointestinal motility disorders in inflammatory bowel diseases 4
Immunoglobulin A Glycosylation Differs between Crohn’s Disease and Ulcerative Colitis 4
Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East 4
Ustekinumab as induction and maintenance therapy for Crohn's disease 4
Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes 4
A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for crohn's disease and celiac disease 4
Long-term results of the European Achalasia trial: A multicentre randomised Controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy 4
Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC) 4
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis 4
Ustekinumab: Moving the target from psoriasis to Crohn's disease 4
Small Bowel Adenocarcinoma in Crohn's Disease: An Underestimated Risk? 4
Capsule endoscopy in Crohn's disease: Is there enough light in the tunnel? 4
Percutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles 3
Emerging drug for diarrhea predominant irritable bowel syndrome 3
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review 3
Review article: The natural history of paediatric-onset ulcerative colitis in population-based studies 3
Vitamin D regulates the tight-junction protein expression in active ulcerative colitis 3
Erratum: Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: Results from a double-blind, randomized, parallel group study (American Journal of Gastroenterology (2015) 110 (708-715) DOI: 10.1038/ajg.2015.114) 3
European evidence-based consensus: Inflammatory bowel disease and malignancies 3
Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease 3
The genetic burden of inflammatory bowel diseases: implications for the clinic? 3
Genetic variation in the lymphotoxin-α (LTA)/tumour necrosis factor-α (TNFα) locus as a risk factor for idiopathic achalasia 3
The role of glycosylation in IBD 3
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 3
Association between polymorphisms in antioxidant genes and inflammatory bowel disease 3
ECCO IBD curriculum 3
Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany 3
Results of the 4th Scientific Workshop of the ECCO (Group II): Markers of intestinal fibrosis in inflammatory bowel disease 3
Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy 3
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants 3
Totale 1.689
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.445
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2021/202230 0 0 0 27 0 0 0 0 0 1 0 2
2022/2023118 60 26 1 1 2 15 2 3 8 0 0 0
2023/20241.240 93 8 31 57 13 60 5 25 5 9 496 438
2024/2025613 254 33 44 205 77 0 0 0 0 0 0 0
Totale 2.003